Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease-Reference-Cited by-同舟云学术

Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease

Published:2017-11-28 Issue:suppl_1 Volume:10 Page:i9-i15
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Roger Simon D

Funder

Vifor Pharma

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/10/suppl_1/i9/22089012/sfx100.pdf

Reference66 articles.

1. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?;Adv Chronic Kidney Dis,2009

2. Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis;Nephrology (Carlton),2016

3. KDIGO clinical practice guideline for anemia in chronic kidney disease;Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group;Kidney Int Suppl,2012

4. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD;Am J Kidney Dis,2013

5. Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European renal best practice position statement;Nephrol Dial Transplant,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of iron (III) hydroxide sucrose complex (Ranofer) and other iron preparations on body iron store in long term hemodialysis patients – A retrospective cohort study;2022-10-03

2. Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD;Kidney360;2022-09-29

3. The Effects of Preoperative Administration of Erythropoietin in Pediatric Patients Undergoing Cranial Vault Remodeling for Craniosynostosis;Journal of Craniofacial Surgery;2022-06-27

4. Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress;Oxidative Medicine and Cellular Longevity;2022-04-14

5. Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study;Canadian Journal of Kidney Health and Disease;2022-01